Content area

|
|

Cannabis og glaukom

Cannabis-plante.
Forfatter(e)
Zaynab Ahmad Mouhammad1 & Miriam Kolko1, 2 1) Institut for Lægemiddeldesign og Farmakologi, Københavns Universitet 2) Øjenafdelingen, Rigshospitalet Ugeskr Læger 2018;180:V11170861
Reference: 
Ugeskr Læger 2018;180:V11170861
Sidetal: 
2-6
Should ophtalmologists recommend medical cannabis to patients with glaucoma?
Cannabis has been widely used for various medical purposes since before year 2000 BC. Its effects are mediated by cannabinoids and stimulation of mainly G-protein coupled cannabinoid receptors. In 1971, subjects who smoked marihuana, showed a decrease in the intraocular pressure. Later investigations additionally revealed a neuroprotective effect of both ∆-9-tetrahydrocannabinol and cannabidiol (CBD). Furthermore, CBD was found to promote neurogenesis. The aim of this review is to provide an overview of the potential use of cannabinoids in the treatment of glaucoma.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Frederik Liljefred | 23/10
1 Kommentar
af Kirsten Anne M. Olesen | 23/10
3 kommentarer
af Else Lyngsøe Svejgaard | 23/10
3 kommentarer
af Camilla Bang | 21/10
3 kommentarer
af Anne Gersdorff Korsgaard | 20/10
1 Kommentar
af Karen Brink Linnet | 19/10
1 Kommentar
af Thor Andersen Knudsen | 19/10
2 kommentarer
af Ole Lindgård Dollerup | 18/10
1 Kommentar
af Kristine Rasmussen | 18/10
1 Kommentar